References
- 1. W. Sneader, Drug Discovery. A History, John Wiley & Sons, Chichester 2005.10.1002/0470015535
- 2. D. T. Courtwright, Forces of Habit – Drugs and the Making of the Modern World, Harvard University Press, Cambridge (MA) 2002.10.4159/9780674029903
- 3. M. Hanada, Case Studies in Modern Drug Discovery and Development, John Wiley & Sons, Hoboken (NJ) 2012.
- 4. D. A. Dias, S. Urban and U. Roessner, A historical overview of natural products in drug discovery, Metabolites2 (2012) 303–336; https://doi.org/10.3390/metabo202030310.3390/metabo2020303390120624957513
- 5. M. Friedman, Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (Lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds, J. Agric. Food Chem. 63 (2015) 7108–7123; https://doi.org/10.1021/acs.jafc.5b0291410.1021/acs.jafc.5b0291426244378
- 6. X. He, X. Wang, J. Fang, Y. Chang, N. Ning, H. Guo, L. Huang, X. Huang and Z. Zhao, Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s mane) mushroom: A review, Int. J. Biol. Macromol. 97 (2017) 228–237; https://doi.org/10.1016/j.ijbiomac.2017.01.04010.1016/j.ijbiomac.2017.01.04028087447
- 7. G. Wang, X. Zhang, S. E. Maier, L. Zhang and R. J. Maier, In vitro and in vivo inhibition of Helicobacter pylori by ethanolic extracts of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), Int. J. Med. Mushrooms21 (2019) 1–11; https://doi.org/10.1615/IntJMedMush-rooms.201802948710.1615/IntJMedMushrooms.2018029487
- 8. M. Qin, Y. Geng, Z. Lu, H. Xu, J. S. Shi, X. Xu and Z. H. Xu, Antiinflammatory effects of ethanol extract of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), in mice with ulcerative colitis, Int. J. Med. Mushrooms18 (2016) 227–234; https://doi.org/10.1615/IntJMedMush-rooms.v18.i3.5010.1615/IntJMedMushrooms.v18.i3.50
- 9. M. Wang, T. Konishi, Y. Gao, D. Xu and Q. Gao, Anti-gastric ulcer activity of polysaccharide fraction isolated from mycelium culture of Lion’s mane medicinal mushroom, Hericium erinaceus (higher Basidiomycetes), Int. J. Med. Mushrooms17 (2015) 1055–1060; https://doi.org/10.1615/intjmedmushrooms.v17.i11.5010.1615/IntJMedMushrooms.v17.i11.50
- 10. W. Li, W. Zhou, E. J. Kim, S. H. Shim, H. K. Kang and Y. H. Kim, Isolation and identification of aromatic compounds in Lion’s Mane Mushroom and their anticancer activities, Food Chem. 170 (2015) 336–342; https://doi.org/10.1016/j.foodchem.2014.08.07810.1016/j.foodchem.2014.08.07825306354
- 11. S. P. Kim, M. Y. Kang, Y. H. Choi, J. H. Kim, S. H. Nam and M. Friedman, Mechanism of Hericium erinaceus (yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells, Food Funct.2 (2011) 348–356; https://doi.org/10.1039/c1fo10030k10.1039/c1fo10030k21779573
- 12. M. Wang, Y. Zhang, X. Xiao, D. Xu, Y. Gao and Q. Gao, A polysaccharide isolated from mycelia of the Lion’s mane medicinal mushroom Hericium erinaceus (Agaricomycetes) induced apoptosis in precancerous human gastric cells, Int. J. Med. Mushrooms19 (2017) 1053–1060; https://doi.org/10.1615/IntJMedMushrooms.201702497510.1615/IntJMedMushrooms.201702497529431066
- 13. X. Zan, F. Cui, Y. Li, Y. Yang, D. Wu, W. Sun and L. Ping, Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis, Int. J. Biol. Macromol. 76 (2015) 242–253; https://doi.org/10.1016/j.ijbiomac.2015.01.06010.1016/j.ijbiomac.2015.01.06025703932
- 14. Y. Li, G. Zhang, T. B. Ng and H. Wang, A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum, J. Biomed. Biotechnol.2010 (2010) Article ID 716515 (9 pages); https://doi.org/10.1155/2010/71651510.1155/2010/716515
- 15. S. S. Han, C. K. Cho, Y. W. Lee and H. S. Yoo, Antimetastatic and immunomodulating effect of water extracts from various mushrooms, J. Acupunct. Meridian Stud.2 (2009) 218–227; https://doi.org/10.1016/S2005-2901(09)60058-310.1016/S2005-2901(09)60058-3
- 16. X. Sheng, J. Yan, Y. Meng, Y. Kang, Z Han, G. Tai, Y. Zhou and H. Cheng, Immunomodulatory effects of Hericium erinaceus derived polysaccharides are mediated by intestinal immunology, Food Funct.8 (2017) 1020–1027; https://doi.org/10.1039/c7fo00071e10.1039/C7FO00071E28266682
- 17. I.-C. Li, L.-Y. Lee, T.-T. Tzeng, W.-P. Chen, Y.-P. Chen, Y.-J. Shiao and C.-C. Chen, Neurohealth properties of Hericium erinaceus mycelia enriched with erinacines, Behav. Neurol.2018 (2018) 5802634 (10 pages); https://doi.org/10.1155/2018/580263410.1155/2018/5802634598723929951133
- 18. P. Rossi, V. Cesaroni, F. Brandalise, A. Occhinegro, D. Ratto, F. Perrucci, V. Lanaia, C. Girometta, G. Orrù and E. Savino, Dietary supplementation of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), and spatial memory in wild-type mice, Int. J. Med. Mushrooms20 (2018) 485–494; https://doi.org/10.1615/IntJMedMushrooms.201802624110.1615/IntJMedMushrooms.201802624129953363
- 19. P. S. Liu, S. H. Chueh, C. C. Chen, L. Y. Lee and L. Y. Shiu, Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), modulates purinoceptor-coupled calcium signaling and murine nociceptive behavior, Int. J. Med. Mushrooms19 (2017) 499–507; https://doi.org/10.1615/IntJMedMushrooms.v19.i6.2010.1615/IntJMedMushrooms.v19.i6.2029199560
- 20. C.-C. Zhang, X. Yin, C.-Y. Cao, J. Wei, Q. Zhang and J.-M. Gao, Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells, Bioorg. Med. Chem. Lett.25 (2015) 5078–5082; https://doi.org/10.1016/j.bmcl.2015.10.01610.1016/j.bmcl.2015.10.01626481911
- 21. K. Mori, S. Inatomi, K. Ouchi, Y. Azumi and T. Tuchida, Improving effects of the mushroom yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial, Phytother. Res.23 (2009) 367–372; https://doi.org/10.1002/ptr.263410.1002/ptr.263418844328
- 22. M. Nagano, K. Shimizu, R. Kondo, C. Hayashi, D. Sato, K. Kitagawa and K. Ohnuki, Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomed. Res.31 (2010) 231–237; https://doi.org/10.2220/biomedres.31.23110.2220/biomedres.31.23120834180
- 23. A. Blagodatski, M. Yatsunskaya, V. Mikhailova, V. Tiasto, A. Kagansky and V. L. Katanaev, Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy, Oncotarget9 (2018) 29259–29274; https://doi.org/10.18632/oncotarget.2566010.18632/oncotarget.25660604437230018750
- 24. L. J. Standish, C. A. Wenner, E. S. Sweet, C. Bridge, A. Nelson, M. Martzen, J. Novack and C. Torkelson, Trametes versicolor mushroom immune therapy in breast cancer, J. Soc. Integr. Oncol.6 (2008) 122–128.
- 25. K. Oba, S. Teramukai, M. Kobayashi, T. Matsui, Y. Kodera and J. Sakamoto, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer, Cancer Immunol. Immunother.56 (2007) 905–911; https://doi.org/10.1007/s00262-006-0248-110.1007/s00262-006-0248-117106715
- 26. J. Sakamoto, S. Morita, K. Oba, T. Matsui, M. Kobayashi, H. Nakazato and Y. Ohashi, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials, Cancer Immunol. Immunother. 55 (2006) 404–411; https://doi.org/10.1007/s00262-005-0054-110.1007/s00262-005-0054-116133112
- 27. K. Sugimachi, K. Inokuchi and H. Matsuura, Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival, Jpn. J. Surg.14 (1984) 217–221.10.1007/BF024695716748393
- 28. Y. Iino, T. Yokoe, M. Maemura, J. Horiguchi, H. Takei, S. Ohwada and Y. Morishita, Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer, Anticancer Res. 15 (1995) 2907–2911.
- 29. L. Zhong, P. Yan, W. C. Lam, L. Yao and Z. Bian, Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: A systematic review and meta-analysis of randomized controlled trials, Front. Pharmacol. 10 (2019) 703 (14 pages); https://doi.org/10.3389/fphar.2019.0070310.3389/fphar.2019.00703661631031333449
- 30. H. Lu, Y. Yang, E. Gad, C. Inatsuka, C. A. Wenner, M. L. Disis and L. J. Standish, TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy, Clin. Cancer Res. 17 (2011) 6742–6753; https://doi.org/10.1158/1078-0432.CCR-11-114210.1158/1078-0432.CCR-11-1142320698721918170
- 31. H. Lu, Y. Yang, E. Gad, C. A. Wenner, A. Chang, E. R. Larson, Y. Dang, M. Martzen, L. J. Standish and M. L. Disis, Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells, Clin. Cancer Res. 17 (2011) 67–76; https://doi.org/10.1158/1078-0432.CCR-10-176310.1158/1078-0432.CCR-10-1763301724121068144
- 32. K. Quayle, C. Coy, L. Standish and H. Lu, The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan, J. Nat. Med. 69 (2015) 198–208; https://doi.org/10.1007/s11418-014-0879-z10.1007/s11418-014-0879-z25510899
- 33. Z. Wang, B. Dong, Z. Feng, S. Yu and Y. Bao, A study on immunomodulatory mechanism of polysaccharopeptide mediated by TLR4 signaling pathway, BMC Immunol. 16 (2015) Article ID 34 (9 pages); https://doi.org/10.1186/s12865-015-0100-510.1186/s12865-015-0100-5445099426032186
- 34. H. Dou, Y. Chang and L. Zhang, Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Prog. Mol. Biol. Transl. Sci. 163 (2019) 361–381; https://doi.org/10.1016/bs.pmbts.2019.03.00110.1016/bs.pmbts.2019.03.00131030754
- 35. Y. Chang, M. Zhang, Y. Jiang, Y. Liu, H. Luo, C. Hao, P. Zeng and L. Zhang, Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Discov. Med. 23 (2017) 207–219.
- 36. F. Hong, R.. Hansen, J. Yan D. Allendorf, J. Baran, G. Ostroff and G. Ross, Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells, Cancer Res. 63 (2003) 9023–9031; https://cancerres.aacrjournals.org/content/63/24/9023.long
- 37. S. Modak, G. Koehne, A. Vickers, R. O’Reilly and N.-K. V. Cheung, Rituximab therapy of lymphoma is enhanced by orally administered (1®3),(1®4)-D-β-glucan, Leuk. Res. 29 (2005) 679–683; https://doi.org/10.1016/j.leukres.2004.10.00810.1016/j.leukres.2004.10.00815863209
- 38. M. Thomas, P. Sadjadian, J. Kollmeier, J. Lowe, P. Mattson, J. R. Trout, M. Gargano, M. L. Patchen, R. Walsh, M. Beliveau, J. F. Marier, N. Bose, K. Gorden and F. Schneller III, A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer, Invest. New Drugs35 (2017) 345–358; https://doi.org/10.1007/s10637-017-0450-310.1007/s10637-017-0450-3541830728303530
- 39. N. H. Segal, P. Gada, N. Senzer, M. Gargano, M. Patchen and L. Saltz, A phase II efficacy and safety, open-label, multicenter study of imprime PGG injection in combination with cetuximab in patients with stage IV KRAS-mutant colorectal cancer, Clin. Colorectal Cancer15 (2016) 222–227; https://doi.org/10.1016/j.clcc.2016.02.01310.1016/j.clcc.2016.02.013562151926975418
- 40. H. Asai, H. Iijima, K. Matsunaga, Y. Oguchi, H. Katsuno and K. Maeda, Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling, Cancer Immunol. Immunother.57 (2008) 1647–1655; https://doi.org/10.1007/s00262-008-0498-110.1007/s00262-008-0498-118343922
- 41. A. L. Engel, G. C. Sun, E. Gad, L. R. Rastetter, K. Strobe, Y. Yang, Y. Dang, M. L. Disis and H. Lu, Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant, Immunobiology218 (2013) 1468–1476; https://doi.org/10.1016/j.imbio.2013.05.00110.1016/j.imbio.2013.05.001378351923735481
- 42. M. Kato, K. Hirose, M. Hakozaki, M. Ohno, Y. Saito, R. Izutani, J. Noguchi, Y. Hori, S. Okumoto, D. Kuroda, H. Nomura, S. Nishimatsu and H. Ohoyanagi, Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide, Cancer Immunol. Immunother.40 (1995) 152–156.10.1007/BF015173467728773
- 43. C. B. Lau, C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. H. Chan and M. S. Chow, Cytotoxic activities of Coriolus versicolor (yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis, Life Sci.75 (2004) 797–808; https://doi.org/10.1016/j.lfs.2004.04.00110.1016/j.lfs.2004.04.00115183073
- 44. C. Inatsuka, Y. Yang, E. Gad, L. Rastetter, M. L. Disis and H. Lu, Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK, Cancer Immunol. Immunother.62 (2013) 1335–1345; https://doi.org/10.1007/s00262-013-1436-410.1007/s00262-013-1436-4372762923685781
- 45. C. J. Torkelson, E. Sweet, M. R. Martzen, M. Sasagawa, C. A. Wenner, J. Gay, A. Putiri and L. J. Standish, Phase 1 clinical trial of Trametes versicolor in women with breast cancer, ISRN Oncol. 2012 (2012) 251632 (7 pages); https://doi.org/10.5402/2012/25163210.5402/2012/251632336947722701186
- 46. B. K. Sekhon, D. M. Sze, W. K. Chan, K. Fan, G. Q. Li, D. E. Moore and R. H. Roubin, PSP activates monocytes in resting human peripheral blood mononuclear cells: immunomodulatory implications for cancer treatment, Food Chem. 138 (2013) 2201–2209; https://doi.org/10.1016/j.food-chem.2012.11.00910.1016/j.foodchem.2012.11.009
- 47. C. A. Wenner, M. R. Martzen, H. Lu, M. R. Verneris, H. Wang and J. W. Slaton, Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer, Int. J. Oncol. 40 (2012) 905–913; https://doi.org/10.3892/ijo.2011.129210.3892/ijo.2011.1292358455522159900
- 48. Q. Y. Hu, H. Wang, W. M. Shen, X. R. Chen and M. Zou, Promoting effects of polysaccharide of Polysticius versicolor (L) FR. in C57BL/6J mice bearing melanoma B16, Chin. J. Antibiot. 6 (1988) 425–431.
- 49. S. Xu, Y. H. Song, H. Li and H. B. Cai, Curative effect observation on advanced colorectal cancer by the treatment with PSP combined with XELOX regimen, Acta Univ. Med. Nanjing12 (2008) 1616–1618.
- 50. H. Fritz, D. A. Kennedy, M. Ishii, D. Fergusson, R. Fernandes, K. Cooley and D. Seely, Polysaccharide K and Coriolus versicolor extracts for lung cancer: A systematic review, Integr. Cancer Ther. 14 (2015) 201–211; https://doi.org/10.1177/153473541557288310.1177/153473541557288325784670
- 51. A. Knežević, M. Stajić, I. Sofrenić, T. Stanojković, I. Milovanović, V. Tešević and J. Vukojević, Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia, PLoS ONE13 (2018) e0203064 (18 pages); https://doi.org/10.1371/journal.pone.020306410.1371/journal.pone.0203064611837330169542
- 52. L. Janjušević, B. Pejin, S. Kaišarević, S. Gorjanović, F. Pastor, K. Tešanović and M. Karaman, Trametes versicolor ethanol extract, a promising candidate for health-promoting food supplement, Nat. Prod. Res. 32 (2018) 963–967; https://doi.org/10.1080/14786419.2017.136648410.1080/14786419.2017.136648428817965
- 53. C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. Chan and C. B. Lau, Differential anti-tumor activity of coriolus versicolor (yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells, Cancer Biol. Ther. 4 (2005) 638–644; https://doi.org/10.4161/cbt.4.6.172110.4161/cbt.4.6.172115908782
- 54. D. Roca-Lema, O. Martinez-Iglesias, C. Fernández de Ana Portela, A. Rodríguez-Blanco, M. Valladares-Ayerbes, A. Díaz-Díaz, A. Casas-Pais, C. Prego and A. Figueroa, In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes versicolor and Grifola frondosa in colon cancer cells, Int. J. Med. Sci.16 (2019) 231–240; https://doi.org/10.7150/ijms.2881110.7150/ijms.28811636752230745803
- 55. T.-C. Hsieh, J. Kunicki, Z. Darzynkiewicz and J. M. Wu, Effects of extracts of Coriolus versicolor (I’m-Yunity™) on cell-cycle progression and expression of interleukins-1β, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes, J. Altern. Complement. Med. 8 (2002) 591–602; https://doi.org/10.1089/10755530232082510110.1089/10755530232082510112470440
- 56. N. Hirahara, M. Fujioka, T. Edamatsu, A. Fujieda, F. Sekine, T. Wada and T. Tanaka, Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells, Anticancer Res. 31 (2011) 2733–2738.
- 57. T. S. Hattori, N. Komatsu, S. Shichijo and K. Itoh, Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa, Biomed. Pharmacother. 58 (2004) 226–230; https://doi.org/10.1016/j.biopha.2004.02.00410.1016/j.biopha.2004.02.00415183847
- 58. C. Iguchi, Y. Nio, H. Takeda, K. Yamasawa, N. Hirahara, T. Toga, M. Itakura and K. Tamura, Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface, Anticancer Res. 21 (2001) 1007–1013.
- 59. S. F. Yang, T. F. Zhuang, Y. M. Si, K. Y. Qi and J. Zhao, Coriolus versicolor mushroom polysaccha-rides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways, Mol. Immunol. 64 (2015) 144–151; https://doi.org/10.1016/j.molimm.2014.11.00710.1016/j.molimm.2014.11.00725480394
- 60. H. Zhang, T. Morisaki, C. Nakahara, H. Matsunaga, N. Sato, F. Nagumo, J. Tadano and M. Katano, PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1, Oncogene22 (2003) 2088–2096; https://doi.org/10.1038/sj.onc.120631010.1038/sj.onc.120631012687011
- 61. E. Jiménez-Medina, E. Berruguilla, I. Romero, I. Algarra, A. Collado, F. Garrido and A. Garcia-Lora, The immunomodulator PSK induces in vitro cytotoxic activity in tumor cell lines via arrest of cell cycle and induction of apoptosis, BMC Cancer8 (2008) Article ID 78 (10 pages); https://doi.org/10.1186/1471-2407-8-7810.1186/1471-2407-8-78229147118366723